Hypolipidemic effect of polyvinylpyrrolidone in man.
D000328:Adult; D001786:Blood Glucose; D001794:Blood Pressure; D001798:Blood Proteins; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006400:Hematocrit; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D007263:Infusions, Parenteral; D007552:Isotonic Solutions; D008297:Male; D008875:Middle Aged; D010952:Plasma Substitutes / Q000627:therapeutic use; D010953:Plasma Volume; D011188:Potassium / Q000097:blood; D011205:Povidone / Q000008:administration & dosage / Q000627:therapeutic use*; D012964:Sodium / Q000097:blood; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D001798:Blood Proteins; D003911:Dextrans; D007552:Isotonic Solutions; D010952:Plasma Substitutes; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol; D012964:Sodium; D011205:Povidone; D011188:Potassium